Log in | Register

Safety of gelatin for volume resuscitation—a systematic review and meta-analysis

D. O. Thomas-Rueddel| V. Vlasakov| K. Reinhart| R. Jaeschke| H. Rueddel| R. Hutagalung| A. Stacke| C. S. Hartog
Original
Volume 38, Issue 7 / July , 2012

Pages 1134 - 1142

Abstract

Purpose

Gelatin is frequently used as a volume expander in critical care. Our goal was to investigate its safety.

Methods

Systematic review of randomized controlled trials (RCT) in patients receiving gelatin for resuscitation in comparison to albumin or crystalloids.

Results

We identified 40 RCTs published between 1976 and 2010 with 3,275 patients. Median sample size in the gelatin groups was 15 patients (range 10–249). Median gelatin dose was 17 ml/kg (range 6–57 ml/kg). In 32 RCTs (n = 1,946/3,275, 59 % of all patients), the study period was ≤24.0 h. Twenty-nine RCTs (n = 2,001) investigated elective surgical patients, mostly undergoing cardiac surgery (18 RCTs, n = 819). Three RCTs (n = 723) investigated critically ill adults. Two RCTs (n = 59) were performed in emergency room patients, and six RCTs (n = 492) were performed in neonates or children. No study was adequately powered to investigate the frequency of patient-important outcomes. Risks were not statistically significantly different for mortality (RR 1.12, 95 % confidence interval, 0.87–1.44) and exposure to allogeneic transfusion (RR 1.28, 0.89–1.83). On account of only few included studies and the small number of patients, subgroup analyses (high vs. low dose, >24 h vs. shorter periods, and critically ill patients vs. others) were uninformative. Only three RCTs reported the occurrence of acute renal failure.

Conclusion

Despite over 60 years of clinical practice, the safety and efficacy of gelatin cannot be reliably assessed in at least some settings in which it is currently used. We suggest the need to investigate and establish such safety.

Keywords

References

  1. Saddler JM, Horsey PJ (1987) The new generation gelatins. A review of their history, manufacture and properties. Anaesthesia 42:998–1004
    • View reference on PubMed
    • View reference on publisher's website
  2. Hogan JJ (1915) The intravenous use of colloidal (gelatin) solutions in shock. JAMA 64:721–726
    • View reference on publisher's website
  3. Campbell DH, Koepfli JB, Pauling L, Abrahamsen N, Dandliker W, Feigen GA, Lanni F, Le RA (1951) The preparation and properties of a modified gelatin (Oxypolygelatin) as an oncotic substitute for serum albumin. Tex Rep Biol Med 9:235–280
    • View reference on PubMed
  4. Parkins WM, Perlmutt JH, Vars HM (1953) Dextran, oxypolygelatin and modified fluid gelatin as replacement fluids in experimental hemorrhage. Am J Physiol 173:403–410
    • View reference on PubMed
  5. Schmidt-Thome J, Mager A, Schoene HH (1962) On the chemistry of a new plasma expander. Arzneimittelforschung 12:378–380
    • View reference on PubMed
  6. Ziporyn T (1985) The Food and Drug Administration: how those regulations came to be. JAMA 254:2037–2039, 2043–2036
  7. Lundsgaard-Hansen P, Tschirren B (1980) Clinical experience with 120,000 units of modified fluid gelatin. Dev Biol Stand 48:251–256
    • View reference on PubMed
  8. de Jonge E, Levi M (2001) Effects of different plasma substitutes on blood coagulation: a comparative review. Crit Care Med 29:1261–1267
    • View reference on PubMed
    • View reference on publisher's website
  9. Cittanova ML, Leblanc I, Legendre C, Mouquet C, Riou B, Coriat P (1996) Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet 348:1620–1622
    • View reference on PubMed
    • View reference on publisher's website
  10. Schortgen F, Lacherade JC, Bruneel F, Cattaneo I, Hemery F, Lemaire F, Brochard L (2001) Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet 357:911–916
    • View reference on PubMed
    • View reference on publisher's website
  11. Bayer O, Reinhart K, Sakr Y, Kabisch B, Kohl M, Riedemann NC, Bauer M, Settmacher U, Hekmat K, Hartog CS (2011) Renal effects of synthetic colloids and crystalloids in patients with severe sepsis: a prospective sequential comparison. Crit Care Med 39:1335–1342
    • View reference on PubMed
    • View reference on publisher's website
  12. Bayer O, Kohl M, Kabisch B, Sakr Y, Schelenz C, Bauer M, Riedemann N, Badreldin A, Doenst T, Hartog C, Reinhart K (2011) Effects of synthetic colloids on renal function in cardiac surgical patients. Intensive Care Med 37:S202
  13. Perel P, Roberts I (2011) Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane database of systematic reviews (Online) 3:CD000567
  14. Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K (2008) Intensive insulin therapy and pentastarch resuscitation in severe sepsis. New Eng J Med 358:125–139
    • View reference on PubMed
    • View reference on publisher's website
  15. Bunn F, Trivedi D, Ashraf S (2011) Colloid solutions for fluid resuscitation. Cochrane database of systematic reviews (Online) 3:CD001319
  16. Editors in-Chief statement regarding published clinical trials conducted without IRB approval by Joachim Boldt,http://journals.lww.com/ejanaesthesiology/Documents/EIC%20Joint%20Statement%20on%20Retractions%2012Mar2011.pdf. Accessed 12 March 2011 DOI
  17. Higgins JPT, Green S (eds) (2011) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration. http://www.cochrane-handbook.org. Accessed March 2011
  18. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A (2007) Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit Care (London, England) 11:R31
  19. Dung NM, Day NP, Tam DT, Loan HT, Chau HT, Minh LN, Diet TV, Bethell DB, Kneen R, Hien TT, White NJ, Farrar JJ (1999) Fluid replacement in dengue shock syndrome: a randomized, double-blind comparison of four intravenous-fluid regimens. Clin Infect Dis 29:787–794
    • View reference on PubMed
    • View reference on publisher's website
  20. Lorenz W, Duda D, Dick W, Sitter H, Doenicke A, Black A, Weber D, Menke H, Stinner B, Junginger T et al (1994) Incidence and clinical importance of perioperative histamine release: randomised study of volume loading and antihistamines after induction of anaesthesia. Trial Group Mainz/Marburg. Lancet 343:933–940
    • View reference on PubMed
    • View reference on publisher's website
  21. Ngo NT, Cao XT, Kneen R, Wills B, Nguyen VM, Nguyen TQ, Chu VT, Nguyen TT, Simpson JA, Solomon T, White NJ, Farrar J (2001) Acute management of dengue shock syndrome: a randomized double-blind comparison of 4 intravenous fluid regimens in the first hour. Clin Infect Dis 32:204–213
    • View reference on PubMed
    • View reference on publisher's website
  22. Evans PA, Heptinstall S, Crowhurst EC, Davies T, Glenn JR, Madira W, Davidson SJ, Burman JF, Hoskinson J, Stray CM (2003) Prospective double-blind randomized study of the effects of four intravenous fluids on platelet function and hemostasis in elective hip surgery. J Thromb Haemost 1:2140–2148
    • View reference on PubMed
    • View reference on publisher's website
  23. Jin SL, Yu BW (2010) Effects of acute hypervolemic fluid infusion of hydroxyethyl starch and gelatin on hemostasis and possible mechanisms. Clin Appl Thromb Hemost 16:91–98
  24. Schramko AA, Suojaranta-Ylinen RT, Kuitunen AH, Raivio PM, Kukkonen SI, Niemi TT (2010) Comparison of the effect of 6% hydroxyethyl starch and gelatine on cardiac and stroke volume index: a randomized, controlled trial after cardiac surgery. Perfusion 25:283–291
  25. Upadhyay M, Singhi S, Murlidharan J, Kaur N, Majumdar S (2005) Randomized evaluation of fluid resuscitation with crystalloid (saline) and colloid (polymer from degraded gelatin in saline) in pediatric septic shock. Indian Pediatr 42:223–231
    • View reference on PubMed
  26. van der Heijden M, Verheij J, van Nieuw Amerongen GP, Groeneveld AB (2009) Crystalloid or colloid fluid loading and pulmonary permeability, edema, and injury in septic and nonseptic critically ill patients with hypovolemia. Crit Care Med 37:1275–1281
  27. Gondos T, Marjanek Z, Ulakcsai Z, Szabo Z, Bogar L, Karolyi M, Gartner B, Kiss K, Havas A, Futo J (2010) Short-term effectiveness of different volume replacement therapies in postoperative hypovolaemic patients. Eur J Anaesthesiol 27:794–800
  28. Korttila K, Lauritsalo K, Sarmo A, Gordin A, Sundberg S (1983) Suitability of plasma expanders in patients receiving low-dose heparin for prevention of venous thrombosis after surgery. Acta Anaesthesiol Scand 27:104–107
    • View reference on PubMed
    • View reference on publisher's website
  29. Stockwell MA, Scott A, Day A, Riley B, Soni N (1992) Colloid solutions in the critically ill. A randomised comparison of albumin and polygeline 2. Serum albumin concentration and incidences of pulmonary oedema and acute renal failure. Anaesthesia 47:7–9
    • View reference on PubMed
    • View reference on publisher's website
  30. Soares RR, Ferber L, Lorentz MN, Soldati MT (2009) Intraoperative volume replacement: crystalloids versus colloids in surgical myocardial revascularization without cardiopulmonary bypass. Revista brasileira de anestesiologia 59:439–451
    • View reference on PubMed
    • View reference on publisher's website
  31. Mittermayr M, Streif W, Haas T, Fries D, Velik-Salchner C, Klingler A, Oswald E, Bach C, Schnapka-Koepf M, Innerhofer P (2007) Hemostatic changes after crystalloid or colloid fluid administration during major orthopedic surgery: the role of fibrinogen administration. Anesth Analg 105:905–917
    • View reference on PubMed
    • View reference on publisher's website
  32. Akech S, Gwer S, Idro R, Fegan G, Eziefula AC, Newton CR, Levin M, Maitland K (2006) Volume expansion with albumin compared to gelofusine in children with severe malaria: results of a controlled trial. PLoS Clin Trials 1:e21
    • View reference on PubMed
    • View reference on publisher's website
  33. Barron ME, Wilkes MM, Navickis RJ (2004) A systematic review of the comparative safety of colloids. Arch Surg 139:552–563
    • View reference on PubMed
    • View reference on publisher's website
  34. Groeneveld AB, Navickis RJ, Wilkes MM (2011) Update on the comparative safety of colloids: a systematic review of clinical studies. Ann Surg 253:470–483
    • View reference on PubMed
    • View reference on publisher's website
  35. Skinses OK (1947) Gelatin nephrosis; renal tissue changes in man resulting from the intravenous administration of gelatin. Surg Gynecol Obstet 85:563–571
  36. Kief H, Engelbart K, Arnold G, Baehr H (1968) Vacuolar reabsorption of native and digested gelatin (so-called osmotic nephrosis). Virchows Arch Abb B Zellpathol 1:240–250
  37. Hussain SF, Drew PJ (1989) Acute renal failure after infusion of gelatins. BMJ 299:1137–1138
  38. Godet G, Lehot JJ, Janvier G, Steib A, De Castro V, Coriat P (2008) Safety of HES 130/0.4 (Voluven(R)) in patients with preoperative renal dysfunction undergoing abdominal aortic surgery: a prospective, randomized, controlled, parallel-group multicentre trial. Eur J Anaesthesiol 25:986–994
  39. Ooi JS, Ramzisham AR, Zamrin MD (2009) Is 6% hydroxyethyl starch 130/0.4 safe in coronary artery bypass graft surgery? Asian Cardiovasc Thorac Annals 17:368–372

Sign In

Connect with ICM

Top 5 Articles Editors Picks Supplement